Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Current Assets (2020 - 2021)

Updated

Avenue Therapeutics (ATXI) recorded Current Assets of $3.96 million in Q4 2021, up 22.0% from $3.25 million a year earlier.

Analysis

Avenue Therapeutics (ATXI) Current Assets (2020 - 2021) Analysis & Trends

  • Across earlier years, Current Assets came in at $3.25 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 56.35 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 33.67 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 27.97 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 13.95 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 41.36 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 3.96 Mn
Dec 31, 2020 3.25 Mn
API Access

Avenue Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ATXI&period=max&api_key=YOUR_API_KEY